Keyword: Active Pharmaceutical Ingredients (APIs)

News

Transatlantic Deal Simplifies Pharma Inspections

07.03.2017 - Regulators in the EU and the US have signed a transatlantic agreement to recognize inspections of manufacturing sites for human medicines carried out in their respective countries...

Chemistry & Life Sciences

Ferak Berlin Receives GMP Certification

27.01.2017 - Berlin, Germany-based provider of contract research & development and custom manufacturing services, Ferak, has received GMP certification by the Berlin State Office for Health and...

News

Lonza Captures Capsugel for $5.5 Billion

16.12.2016 - Lonza has clinched the mooted deal to buy Capsugel, a Morristown, New Jersey, USA-based producer of capsules for delivery of drugs and food supplements, from US private equity...

Research & Innovation

The Winning Formula

06.12.2016 - Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...

News

Cambrex Validates Milan API Pilot Plant

05.10.2016 - US life sciences company Cambrex has completed and validated a new pilot plant at its manufacturing and R&D site in Paullo, Milan, Italy. Built to meet customer demand for small...

News

BASF Inaugurates China PVP Plant

30.09.2016 - BASF has inaugurated a new production complex for polyvinylpyrrolidone (PVP) at its site in Shanghai, China. The new facility, which will produce PVP K30 powder for several...

Chemistry & Life Sciences

Cambrex Announces Investment & Expansion

16.09.2016 - Cambrex, the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), has announced a SEK 72 million ($9 million) investment to expand...

Plant Construction & Process Technology

ISPE Recognizes Leaders in Drug Shortage Prevention

12.09.2016 - The International Society for Pharmaceutical Engineering (ISPE) recognized 2016 category winners Baxter BioPharma Solutions and Janssen Vaccines for their exceptional leadership in...